Piramal Enterprises Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Piramal Enterprises Limited with three other
companies in this sector in India:
Glenmark Pharmaceuticals Ltd
sales of 91.86 billion Indian Rupees [US$1.43 billion]
Jubilant Life Sciences Limited
(58.61 billion Indian Rupees [US$914.38 million]
of which 53%
was Pharmaceuticals), and
Cadila Healthcare Ltd
(94.30 billion Indian Rupees [US$1.47 billion]
of which 100%
was Pharmaceutical Products).
Piramal Enterprises Limited reported sales of 85.04 billion Indian Rupees (US$1.33 billion)
March of 2017.
increase of 28.7%
versus 2016, when the company's sales were 66.10 billion Indian Rupees.
Sales at Piramal Enterprises Limited have increased during each of the previous five years
(and since 2012, sales have increased a total of 308%).